-+ 0.00%
-+ 0.00%
-+ 0.00%

Jade Biosciences Enters Exclusive Worldwide License Agreement With Paragon Therapeutics; To Pay Up To $22M In Milestone Payments To Paragon; To Pay Paragon Low To Mid-Single-Digit Percentage Royalties On Net Sales Of Licensed Products; Paragon Barred From New Campaigns Targeting Licensed Target For At Least Five Years

Benzinga·07/01/2026 21:20:01
Listen to the news

-SEC Filing